Clinical Trial Update: Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer [NA]

View source ↗

Summary

This clinical trial update reports completed results evaluating tumor markers for the efficacy of a dual-target therapy in HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Nanlin Li | Conditions: HER2-positive Breast Cancer | NA | Status: COMPLETED